Cargando…
Mutated circulating tumor DNA as a liquid biopsy in lung cancer detection and treatment
Over the past decade, substantial developments have been made in the detection of circulating tumor DNA (ctDNA)—cell‐free DNA (cfDNA) fragments released into the circulation from tumor cells and displaying the genetic alterations of those cells. As such, ctDNA detected in liquid biopsies serves as a...
Autores principales: | Filipska, Martyna, Rosell, Rafael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169447/ https://www.ncbi.nlm.nih.gov/pubmed/33969622 http://dx.doi.org/10.1002/1878-0261.12983 |
Ejemplares similares
-
Circulating tumor cells and DNA as liquid biopsies
por: Heitzer, Ellen, et al.
Publicado: (2013) -
Capturing Genomic Evolution of Lung Cancers through Liquid Biopsy for Circulating Tumor DNA
por: Offin, Michael, et al.
Publicado: (2017) -
Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
por: Ye, Qianwei, et al.
Publicado: (2019) -
Liquid Biopsy-Analysis of Circulating Tumor DNA (ctDNA) in Bladder Cancer
por: Todenhöfer, Tilman, et al.
Publicado: (2018) -
Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer
por: Cheng, Feifei, et al.
Publicado: (2016)